Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-severe Pain Following Abdominal Surgery

NCT06904248 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Participants With Acute Moderate to Severe Pain Following Abdominal Surgery

Interventions

DRUG: Meloxicam Injection
DRUG: Sodium Chloride Injection

Sponsor

Yangtze River Pharmaceutical Group Co., Ltd.